As sotalol and pirinixic acid treatment both upregulate irisin expression, and pirinixic acid has hypertension mediating effects, it is probable that sotalol also exhibits anti-hypertensive properties [40,41]. This evidence concerns the gene FNDC5 and Hypertension.